Wentworth Kerry
CHIEF REGULATORY OFFICER
Wentworth Kerry has filed 3 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jun 24, 2026.
On the most recent filing, Wentworth Kerry is listed as CHIEF REGULATORY OFFICER at Nuvation Bio Inc. Inside the rolling window, Wentworth Kerry reported no open-market purchases and 3 open-market sales totaling $1.5M in NUVB. The largest disclosed transaction in the window is a sale of 200,000 NUVB shares on Apr 6, 2026, worth $904K.
Companies traded
Other insiders at NUVB
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.5M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Wentworth Kerry made?
Wentworth Kerry has filed 3 SEC Form 4 filings (7 transaction rows) across 1 company since 2026.
Which companies does Wentworth Kerry trade?
Wentworth Kerry has filed SEC Form 4 disclosures for 1 company, including NUVB.
When was Wentworth Kerry's most recent SEC Form 4 filing?
Wentworth Kerry's most recent SEC Form 4 filing on Tracefour is dated Jun 24, 2026.
What is Wentworth Kerry's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Wentworth Kerry is listed as CHIEF REGULATORY OFFICER.
What is Wentworth Kerry's total buy and sell value in the current window?
Inside the rolling retention window, Wentworth Kerry bought $0 and sold $1.5M based on SEC Form 4 filings.
What was Wentworth Kerry's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 200,000 NUVB shares on 2026-04-06, worth $904K, per SEC Form 4 filings.